- RecruitingPHASE1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
This study is testing a new medicine called lunresertib, by itself or with other medicines (RP-3500 or Debio 0123), for people with advanced solid tumours. It aims to see if they are safe, what dose works best, and if they help shrink tumours.
For: Advanced Solid TumorUnited States · Canada · Denmark - RecruitingPHASE2
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
This study looks at new ways to treat advanced breast cancer that has stopped responding to standard treatments. By checking your blood or tumour for specific signs, doctors hope to find the best treatment for you, exploring several new drugs and combinations.
For: Breast CancerCanada